Yunpeng Pharmaceutical Group Co., Ltd.
As of 18 November 2026, for the company name Yunpeng Pharmaceutical Group Co., Ltd. as recorded, the chemical-drug catalogue lists 24 active records with this name as holder; 73 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
70 acceptance records as first applicant, grouped into 53 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Metoprolol Tartrate Tablets 2 records · Latest accepted 2026/11/17
Generic · 2
Brexpiprazole Orally Disintegrating Tablets 2 records · Latest accepted 2026/11/16
Generic · 2
Ambroxol Hydrochloride Oral Solution 1 records · Latest accepted 2026/11/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602757 | Generic | 2026/11/09 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Levocetirizine dihydrochloride Oral Solution 2 records · Latest accepted 2026/09/22
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601792 | Supplement | 2026/09/22 | Yunpeng Pharmaceutical Group Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601791 | Supplement | 2026/09/22 | Yunpeng Pharmaceutical Group Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
Aminophylline Tablets 1 records · Latest accepted 2026/09/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650187 | Supplement | 2026/09/11 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2026/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601513 | Supplement | 2026/08/10 | Yunpeng Pharmaceutical Group Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanized | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) 1 records · Latest accepted 2026/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601514 | Supplement | 2026/08/10 | Yunpeng Pharmaceutical Group Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanized | CDE ↗ |
甲氧氯普胺片 · No verified English name 1 records · Latest accepted 2026/05/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601213 | Generic | 2026/05/29 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 6 records · Latest accepted 2026/05/14
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601152 | Generic | 2026/05/14 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2601151 | Generic | 2026/05/14 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2601150 | Generic | 2026/05/14 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2503198 | Generic | 2025/08/30 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2503197 | Generic | 2025/08/30 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2503196 | Generic | 2025/08/30 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
Propranolol Hydrochloride Tablets 2 records · Latest accepted 2026/04/21
Supplement · 2
Ibuprofen Suspension 1 records · Latest accepted 2026/04/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600790 | Generic | 2026/04/08 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Betahistine Mesilate Tablets 1 records · Latest accepted 2026/04/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600786 | Generic | 2026/04/08 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Ilaprazole Enteric-coated Tablets 1 records · Latest accepted 2026/03/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600605 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Finerenone Tablets 2 records · Latest accepted 2026/03/27
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600609 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| CYHB2600608 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
Eperisone Hydrochloride Tablets 1 records · Latest accepted 2026/03/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600666 | Generic | 2026/03/16 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Iguratimod Tablets 1 records · Latest accepted 2026/03/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600508 | Supplement | 2026/03/13 | Yunpeng Pharmaceutical Group Co., Ltd.; JIANGSU YONGAN PHARMACEUTICAL CO., LTD | CDE ↗ |
维生素B6注射液 · No verified English name 1 records · Latest accepted 2026/01/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600170 | Supplement | 2026/01/28 | Yunpeng Pharmaceutical Group Co., Ltd.; E Mei Shan Tong Hui Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2026/01/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600207 | Generic | 2026/01/17 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Vortioxetine Hydrobromide Tablets 2 records · Latest accepted 2025/12/25
Generic · 2
Dapagliflozin Tablets 1 records · Latest accepted 2025/12/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504385 | Generic | 2025/12/25 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Riociguat Tablets 3 records · Latest accepted 2025/12/05
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504179 | Generic | 2025/12/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHS2504178 | Generic | 2025/12/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHS2504177 | Generic | 2025/12/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Torsemide Injection 2 records · Latest accepted 2025/11/11
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502321 | Supplement | 2025/11/11 | Yunpeng Pharmaceutical Group Co., Ltd.; Shanxi Pu De Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2502320 | Supplement | 2025/11/11 | Yunpeng Pharmaceutical Group Co., Ltd.; Shanxi Pu De Pharma Co., Ltd. romanized | CDE ↗ |
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2025/11/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503860 | Generic | 2025/11/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Diclofenac Sodium Sustained Release Tablets 1 records · Latest accepted 2025/10/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503698 | Generic | 2025/10/16 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Trihexyphenidyl Hydrochloride Tablets 1 records · Latest accepted 2025/09/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503445 | Generic | 2025/09/18 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
苯磺酸左氨氯地平片 · No verified English name 1 records · Latest accepted 2025/09/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503458 | Generic | 2025/09/18 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2025/07/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502691 | Generic | 2025/07/25 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution 1 records · Latest accepted 2025/06/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501156 | Supplement | 2025/06/10 | Yunpeng Pharmaceutical Group Co., Ltd.; Jewim Pharmaceutical (Shandong) Co., Ltd. | CDE ↗ |
诺氟沙星胶囊 · No verified English name 1 records · Latest accepted 2025/06/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550206 | Supplement | 2025/06/04 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Sitagliptin Phosphate Tablets 1 records · Latest accepted 2025/05/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501933 | Generic | 2025/05/30 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Tadalafil Tablets 1 records · Latest accepted 2025/05/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501800 | Generic | 2025/05/17 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2025/05/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501722 | Generic | 2025/05/13 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil Tablets 1 records · Latest accepted 2025/04/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501349 | Generic | 2025/04/09 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Azithromycin for Suspension 1 records · Latest accepted 2025/03/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501185 | Generic | 2025/03/26 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Apixaban Tablets 1 records · Latest accepted 2025/03/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501024 | Generic | 2025/03/12 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Lamotrigine Tablets 2 records · Latest accepted 2025/03/01
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500410 | Supplement | 2025/03/01 | Yunpeng Pharmaceutical Group Co., Ltd.; Jewim Pharmaceutical (Shandong) Co., Ltd. | CDE ↗ |
| CYHB2500409 | Supplement | 2025/03/01 | Yunpeng Pharmaceutical Group Co., Ltd.; Jewim Pharmaceutical (Shandong) Co., Ltd. | CDE ↗ |
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/12/10
Generic · 2
Furosemide Tablets 1 records · Latest accepted 2024/10/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450539 | Supplement | 2024/10/28 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
二甲双胍恩格列净片(I) · No verified English name 1 records · Latest accepted 2024/09/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403253 | Generic | 2024/09/26 | Yunpeng Pharmaceutical Group Co., Ltd.; Jewim Pharmaceutical (Shandong) Co., Ltd. | CDE ↗ |
Empagliflozin Tablets 1 records · Latest accepted 2024/06/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401650 | Generic | 2024/06/01 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Memantine Hydrochloride Tablets 1 records · Latest accepted 2024/05/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401602 | Generic | 2024/05/29 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Hydrochlorothiazide Tablets 1 records · Latest accepted 2024/04/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450244 | Supplement | 2024/04/15 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Ibuprofen Sustained Release Capsules 1 records · Latest accepted 2024/01/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450063 | Supplement | 2024/01/24 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Omeprazole Enteric Capsules 1 records · Latest accepted 2023/11/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302632 | Supplement | 2023/11/30 | Yunpeng Pharmaceutical Group Co., Ltd.; Shenyang Kang Zhi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Etoricoxib Tablets 2 records · Latest accepted 2023/11/11
Generic · 2
Lactulose Oral Solution 1 records · Latest accepted 2023/11/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303044 | Generic | 2023/11/08 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
硝苯地平缓释片(II) · No verified English name 1 records · Latest accepted 2023/04/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350324 | Supplement | 2023/04/11 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
复合维生素B片 · No verified English name 1 records · Latest accepted 2022/10/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201981 | Supplement | 2022/10/28 | Yunpeng Pharmaceutical Group Co., Ltd.; Tianjin Jin Shi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Gliclazide Modified Release Tablets 1 records · Latest accepted 2022/10/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250626 | Supplement | 2022/10/11 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Linezolid Tablets 1 records · Latest accepted 2022/09/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201556 | Generic | 2022/09/17 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Rosuvastatin Calcium Tablets 1 records · Latest accepted 2021/12/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102181 | Generic | 2021/12/11 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
维生素B6片 · No verified English name 1 records · Latest accepted 2021/11/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2151009 | Supplement | 2021/11/15 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Isoniazid Tablets 1 records · Latest accepted 2021/10/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2102007 | Supplement | 2021/10/19 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Changes in the last 90 days
14 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 applicationAccepted: 7 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 2 applications
- 2026/11/18No longer listed under review
Tadalafil Tablets
CYHS2501800
Fact date: 2026/11/18 · Date added to this site: 2026/11/18
Accepted: 2025/05/17
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/18No longer listed under review
Aspirin Enteric-coated Tablets
CYHS2501722
Fact date: 2026/11/18 · Date added to this site: 2026/11/18
Accepted: 2025/05/13
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/17Accepted
Metoprolol Tartrate Tablets
CYHS2602827
Fact date: 2026/11/17 · Date added to this site: 2026/11/18
View source ↗ - 2026/11/16Accepted
Brexpiprazole Orally Disintegrating Tablets
CYHS2602824
Fact date: 2026/11/16 · Date added to this site: 2026/11/17
View source ↗ - 2026/11/16Accepted
Brexpiprazole Orally Disintegrating Tablets
CYHS2602823
Fact date: 2026/11/16 · Date added to this site: 2026/11/17
View source ↗ - 2026/11/09Accepted
Ambroxol Hydrochloride Oral Solution
CYHS2602757
Fact date: 2026/11/09 · Date added to this site: 2026/11/10
View source ↗ - 2026/10/23No longer listed under review
Levocetirizine dihydrochloride Oral Solution
CYHB2601792
Fact date: 2026/10/23 · Date added to this site: 2026/10/23
Accepted: 2026/09/22
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 26
NMPA · Table row 26 ↗ View source ↗ - 2026/10/23No longer listed under review
Levocetirizine dihydrochloride Oral Solution
CYHB2601791
Fact date: 2026/10/23 · Date added to this site: 2026/10/23
Accepted: 2026/09/22
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 25
NMPA · Table row 25 ↗ View source ↗ - 2026/10/21Supplement delivery
Levocetirizine dihydrochloride Oral Solution
CYHB2601792
Fact date: 2026/10/21 · Publication date: 2026/10/23 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 26 ↗ - 2026/10/21Supplement delivery
Levocetirizine dihydrochloride Oral Solution
CYHB2601791
Fact date: 2026/10/21 · Publication date: 2026/10/23 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 25 ↗ - 2026/10/20Marketing application approved
Azithromycin for Suspension
CYHS2501185 · 国药准字H20266378
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Date added to this site: 2026/11/03
View source · Table row 46 ↗ - 2026/09/22Accepted
Levocetirizine dihydrochloride Oral Solution
CYHB2601792
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/22Accepted
Levocetirizine dihydrochloride Oral Solution
CYHB2601791
Fact date: 2026/09/22 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/11Accepted
Aminophylline Tablets
CYHB2650187
Fact date: 2026/09/11 · Date added to this site: 2026/10/22
View source ↗
Under review
30 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Metoprolol Tartrate Tablets | CYHS2602827 | Generic | 2026/11/17 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | CYHS2602824 | Generic | 2026/11/16 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | CYHS2602823 | Generic | 2026/11/16 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Oral Solution | CYHS2602757 | Generic | 2026/11/09 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Aminophylline Tablets | CYHB2650187 | Supplement | 2026/09/11 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) | CYHB2601514 | Supplement | 2026/08/10 | Yunpeng Pharmaceutical Group Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanized | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | CYHB2601513 | Supplement | 2026/08/10 | Yunpeng Pharmaceutical Group Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanized | CDE ↗ |
| 甲氧氯普胺片 · No verified English name | CYHS2601213 | Generic | 2026/05/29 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2601152 | Generic | 2026/05/14 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2601151 | Generic | 2026/05/14 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2601150 | Generic | 2026/05/14 | Yunpeng Pharmaceutical Group Co., Ltd.; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CDE ↗ |
| Propranolol Hydrochloride Tablets | CYHB2600785 | Supplement | 2026/04/21 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Ibuprofen Suspension | CYHS2600790 | Generic | 2026/04/08 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Betahistine Mesilate Tablets | CYHS2600786 | Generic | 2026/04/08 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Finerenone Tablets | CYHB2600609 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Finerenone Tablets | CYHB2600608 | Supplement | 2026/03/27 | Yunpeng Pharmaceutical Group Co., Ltd.; Medisan Pharmaceutical Co., Ltd.Lanxi | CDE ↗ |
| Eperisone Hydrochloride Tablets | CYHS2600666 | Generic | 2026/03/16 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Iguratimod Tablets | CYHB2600508 | Supplement | 2026/03/13 | Yunpeng Pharmaceutical Group Co., Ltd.; JIANGSU YONGAN PHARMACEUTICAL CO., LTD | CDE ↗ |
| Olmesartan Medoxomil and Amlodipine Besylate Tablets | CYHS2600207 | Generic | 2026/01/17 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | CYHS2504393 | Generic | 2025/12/25 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Dapagliflozin Tablets | CYHS2504385 | Generic | 2025/12/25 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Riociguat Tablets | CYHS2504179 | Generic | 2025/12/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Riociguat Tablets | CYHS2504178 | Generic | 2025/12/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Riociguat Tablets | CYHS2504177 | Generic | 2025/12/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Oseltamivir Phosphate Capsules | CYHS2503860 | Generic | 2025/11/05 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | CYHS2503698 | Generic | 2025/10/16 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | CYHS2503458 | Generic | 2025/09/18 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Trihexyphenidyl Hydrochloride Tablets | CYHS2503445 | Generic | 2025/09/18 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Rosuvastatin Calcium and Ezetimibe Tablets (I) | CYHS2502691 | Generic | 2025/07/25 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Sitagliptin Phosphate Tablets | CYHS2501933 | Generic | 2025/05/30 | Yunpeng Pharmaceutical Group Co., Ltd. | CDE ↗ |
Catalogue holder records
24 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Apixaban Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20266036 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20265942 | 2026/09/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20264526 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20264527 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 诺氟沙星胶囊 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H34020903 | 2026/05/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 维生素B6注射液 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | E Mei Shan Tong Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20264334 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 二甲双胍恩格列净片(I) · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20263673 | 2026/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20256103 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lamotrigine Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20255553 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lamotrigine Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20255552 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20255559 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Furosemide Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H34020909 | 2025/08/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Etoricoxib Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20254037 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20254038 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydrochlorothiazide Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H14020796 | 2025/03/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ibuprofen Sustained Release Capsules | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20123416 | 2025/02/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 硝苯地平缓释片(II) · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20113056 | 2024/03/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20243376 | 2024/03/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Propranolol Hydrochloride Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H14020768 | 2024/02/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gliclazide Modified Release Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20113209 | 2023/10/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rosuvastatin Calcium Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H20233536 | 2023/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metronidazole Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H14022006 | 2021/11/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Isoniazid Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yunpeng Pharmaceutical Group Co., Ltd. | 国药准字H34021587 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ilaprazole Enteric-coated Tablets | Yunpeng Pharmaceutical Group Co., Ltd. | Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20266240 | 2026/10/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
73 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 碳酸氢钠 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000604 | I | 2026/08/12 | CDE ↗ |
| 布洛芬 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000554 | I | 2026/07/23 | CDE ↗ |
| 右莰醇 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000553 | I | 2026/07/09 | CDE ↗ |
| 愈创木酚甘油醚 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000420 | I | 2026/07/09 | CDE ↗ |
| 美索巴莫 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000511 | I | 2026/07/07 | CDE ↗ |
| 酮咯酸氨丁三醇 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000488 | I | 2026/06/17 | CDE ↗ |
| 枸橼酸喷托维林 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000376 | I | 2026/05/13 | CDE ↗ |
| 氯唑沙宗 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000169 | I | 2026/04/14 | CDE ↗ |
| 盐酸乌拉地尔 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000173 | I | 2026/04/10 | CDE ↗ |
| 左西孟旦 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000207 | I | 2026/04/09 | CDE ↗ |
| 盐酸小檗碱 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000114 | I | 2026/03/16 | CDE ↗ |
| 罗沙司他 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000055 | I | 2026/02/10 | CDE ↗ |
| 硫酸镁 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250001406 | I | 2026/01/05 | CDE ↗ |
| 依托考昔 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250001354 | I | 2025/12/18 | CDE ↗ |
| 苯妥英钠 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250001282 | I | 2025/12/05 | CDE ↗ |
| 奥美拉唑 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250001283 | I | 2025/12/03 | CDE ↗ |
| 甲硫酸新斯的明 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250001209 | I | 2025/11/25 | CDE ↗ |
| 硫酸钡(Ⅱ型) · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250001074 | I | 2025/10/15 | CDE ↗ |
| 他达拉非 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000831 | I | 2025/09/09 | CDE ↗ |
| 阿哌沙班 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000892 | I | 2025/08/29 | CDE ↗ |
| 盐酸苯海索 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000723 | I | 2025/08/04 | CDE ↗ |
| 盐酸甲氧氯普胺 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000730 | I | 2025/07/31 | CDE ↗ |
| 重酒石酸间羟胺 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000489 | A | 2026/09/29 | CDE ↗ |
| 多潘立酮 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000531 | I | 2025/06/09 | CDE ↗ |
| 布瑞哌唑 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000268 | A | 2026/08/13 | CDE ↗ |
| 卡托普利 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000288 | A | 2026/08/07 | CDE ↗ |
| 依折麦布 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000047 | A | 2026/07/20 | CDE ↗ |
| 盐酸异丙嗪 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000134 | A | 2026/06/24 | CDE ↗ |
| 曲克芦丁 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001544 | I | 2025/12/17 | CDE ↗ |
| 呋塞米 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20250000026 | A | 2026/06/11 | CDE ↗ |
| 盐酸氨溴索 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001441 | A | 2026/04/21 | CDE ↗ |
| 硫酸双肼屈嗪 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001198 | A | 2026/07/02 | CDE ↗ |
| 氯化铵 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001181 | A | 2026/07/02 | CDE ↗ |
| 盐酸赛庚啶 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001138 | A | 2026/06/23 | CDE ↗ |
| 恩格列净 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001088 | A | 2026/03/13 | CDE ↗ |
| 盐酸地巴唑 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240001035 | A | 2026/07/02 | CDE ↗ |
| 呋喃唑酮 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240000514 | A | 2026/02/13 | CDE ↗ |
| 盐酸苯海拉明 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240000441 | A | 2026/01/22 | CDE ↗ |
| 盐酸坦索罗辛 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20240000170 | A | 2025/11/29 | CDE ↗ |
| 利奥西呱 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230001334 | A | 2025/10/27 | CDE ↗ |
| 盐酸美金刚 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230001198 | A | 2025/11/26 | CDE ↗ |
| 胱氨酸 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230000969 | A | 2025/10/24 | CDE ↗ |
| 吡罗昔康 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230000925 | A | 2025/07/28 | CDE ↗ |
| 富马酸伏诺拉生 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230000746 | A | 2025/08/12 | CDE ↗ |
| 盐酸左旋沙丁胺醇 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230000749 | A | 2026/07/27 | CDE ↗ |
| 西咪替丁 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20230000275 | A | 2025/11/04 | CDE ↗ |
| 呋喃妥因 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20220001060 | A | 2024/12/31 | CDE ↗ |
| 维生素B6 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20220000728 | A | 2024/04/16 | CDE ↗ |
| 甲氧氯普胺 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20220000355 | A | 2025/12/11 | CDE ↗ |
| 利奈唑胺 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20220000344 | A | 2026/01/17 | CDE ↗ |
| 盐酸普萘洛尔 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210001242 | A | 2026/08/28 | CDE ↗ |
| 氢氯噻嗪 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210001243 | A | 2025/11/29 | CDE ↗ |
| 盐酸吗啉胍 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000774 | A | 2025/01/08 | CDE ↗ |
| 异烟肼 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000772 | A | 2024/12/04 | CDE ↗ |
| 瑞舒伐他汀钙 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000652 | A | 2024/11/28 | CDE ↗ |
| 维生素B2 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000568 | A | 2024/01/17 | CDE ↗ |
| 谷维素 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000455 | I | 2023/01/19 | CDE ↗ |
| 硝苯地平 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000454 | A | 2024/12/27 | CDE ↗ |
| 马来酸氯苯那敏 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20210000210 | A | 2024/08/07 | CDE ↗ |
| 泛酸钙 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20200000665 | A | 2024/06/12 | CDE ↗ |
| 盐酸雷尼替丁 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190007892 | A | 2025/07/18 | CDE ↗ |
| 吲哚美辛 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003225 | A | 2025/07/18 | CDE ↗ |
| 磷酸苯丙哌林 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003224 | A | 2025/07/18 | CDE ↗ |
| 硫酸沙丁胺醇 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003223 | A | 2025/07/18 | CDE ↗ |
| 维生素U · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003222 | A | 2025/07/18 | CDE ↗ |
| 诺氟沙星 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003221 | A | 2025/07/18 | CDE ↗ |
| 盐酸环丙沙星 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003220 | A | 2025/11/01 | CDE ↗ |
| 盐酸美西律 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003219 | A | 2024/06/08 | CDE ↗ |
| 亮菌甲素 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003218 | A | 2025/07/18 | CDE ↗ |
| 乳酸环丙沙星 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20190003217 | A | 2025/11/01 | CDE ↗ |
| 羧甲司坦 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20170002285 | A | 2025/04/24 | CDE ↗ |
| 氢溴酸伏硫西汀 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000905 | I | 2026/11/09 | CDE ↗ |
| 重酒石酸去甲肾上腺素 · No verified English name | Yunpeng Pharmaceutical Group Co., Ltd. | Y20260000540 | I | 2026/11/17 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.